URAL Stock Overview
United Rail, Inc. focuses on the provision of upscale commuter Club X railcars for various state Department of Transportation municipal agencies. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
United Rail, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0003 |
52 Week High | US$0.0003 |
52 Week Low | US$0.0002 |
Beta | 0 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | 50.00% |
33 Year Change | -99.99% |
5 Year Change | -100.00% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
URAL | US Transportation | US Market | |
---|---|---|---|
7D | 0% | -3.6% | -2.1% |
1Y | 50.0% | 17.4% | 29.7% |
Return vs Industry: URAL exceeded the US Transportation industry which returned 42.7% over the past year.
Return vs Market: URAL exceeded the US Market which returned 31% over the past year.
Price Volatility
URAL volatility | |
---|---|
URAL Average Weekly Movement | n/a |
Transportation Industry Average Movement | 6.6% |
Market Average Movement | 6.2% |
10% most volatile stocks in US Market | 15.6% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: URAL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine URAL's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Mike Barron | unitedrailinc.com |
United Rail, Inc. focuses on the provision of upscale commuter Club X railcars for various state Department of Transportation municipal agencies. It owns outright 16 bi-level passenger railcars, as well as 2 leased cars. The company was formerly known as Las Vegas Railway Express, Inc. and changed its name to United Rail, Inc. in October 2018.
United Rail, Inc. Fundamentals Summary
URAL fundamental statistics | |
---|---|
Market cap | US$482.00 |
Earnings (TTM) | US$751.00k |
Revenue (TTM) | US$2.02m |
0.0x
P/E Ratio0.0x
P/S RatioIs URAL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
URAL income statement (TTM) | |
---|---|
Revenue | US$2.02m |
Cost of Revenue | US$60.54k |
Gross Profit | US$1.96m |
Other Expenses | US$1.21m |
Earnings | US$751.00k |
Last Reported Earnings
Sep 30, 2018
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did URAL perform over the long term?
See historical performance and comparison